Nano-X Imaging Ltd. (NASDAQ:NNOX – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Nano-X Imaging in a report issued on Monday, June 9th. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings per share of ($0.29) for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Nano-X Imaging’s current full-year earnings is ($0.92) per share.
Several other equities research analysts also recently commented on NNOX. D. Boral Capital reissued a “buy” rating and issued a $10.00 price objective on shares of Nano-X Imaging in a report on Friday, June 6th. Alliance Global Partners restated a “buy” rating on shares of Nano-X Imaging in a research report on Thursday, May 22nd.
Nano-X Imaging Trading Down 3.9%
Shares of NASDAQ:NNOX opened at $5.41 on Wednesday. The stock has a market capitalization of $312.58 million, a P/E ratio of -6.36 and a beta of 1.99. Nano-X Imaging has a 1-year low of $3.75 and a 1-year high of $11.00. The business has a 50-day moving average price of $5.09 and a two-hundred day moving average price of $6.26.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last released its quarterly earnings results on Thursday, May 22nd. The company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The company had revenue of $3.00 million for the quarter, compared to analyst estimates of $3.98 million.
Institutional Investors Weigh In On Nano-X Imaging
Several institutional investors have recently bought and sold shares of NNOX. Kingsview Wealth Management LLC bought a new position in Nano-X Imaging during the 4th quarter valued at approximately $94,000. Rhumbline Advisers increased its stake in Nano-X Imaging by 2.4% during the fourth quarter. Rhumbline Advisers now owns 71,972 shares of the company’s stock worth $518,000 after acquiring an additional 1,655 shares during the last quarter. Quantum Private Wealth LLC bought a new position in shares of Nano-X Imaging during the fourth quarter valued at approximately $72,000. Bank of New York Mellon Corp boosted its holdings in shares of Nano-X Imaging by 4.6% in the fourth quarter. Bank of New York Mellon Corp now owns 146,551 shares of the company’s stock valued at $1,055,000 after purchasing an additional 6,449 shares during the period. Finally, ARK Investment Management LLC lifted its holdings in Nano-X Imaging by 19.0% during the fourth quarter. ARK Investment Management LLC now owns 300,757 shares of the company’s stock worth $2,165,000 after buying an additional 48,124 shares during the period. 21.49% of the stock is currently owned by hedge funds and other institutional investors.
Nano-X Imaging Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Read More
- Five stocks we like better than Nano-X Imaging
- What Are Dividend Champions? How to Invest in the Champions
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- How to Calculate Return on Investment (ROI)
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- How to Invest in Small Cap StocksÂ
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.